Literature DB >> 17981782

TYchi, a novel chitinase with RNA N-glycosidase and anti-tumor activities.

Li Xu1, Ye Wang, Lijiang Wang, Yin Gao, Chengcai An.   

Abstract

Chitinases which catalyze hydrolysis of chitin are believed to be antifungal proteins in plant. Nevertheless, a variety of functions and some new enzymatic activities of chitinases have been found in recent years. We cloned a novel protein from Trichosanthes kirilowii Maximowicz (Family Cucurbitaceae) named TYchi. Expression of TYchi gene in T. kirilowii plants was induced by F. oxysporum, an important cucurbitaceous fungal pathogen, which indicated that TYchi involved in the pathogen-induced plant defense reaction. In addition to its chitin-hydrolytic activity, the recombinant TYchi protein also had RNA N-glycosidase property. In cell-free rabbit reticulocyte lysate system, TYchi inhibited protein synthesis with an IC50 of approximate 5 nM. TYchi also exhibited efficient cytotoxicities to leukemia U937 and choriocarcinoma JAR cells with IC50 about 54 microg ml(-1) and 73 microg ml(-1), respectively. Structure analyses indicated that the putative domain of TYchi is highly similar to the well known active domain of the N-glycosidase trichosanthin (TCS). This bifuntional protein should be useful in diverse applications like RIP-based immunotoxin agent and genetic engineering of plant resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981782     DOI: 10.2741/2914

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  4 in total

1.  Cytotoxicity against tumor cell lines and anti-inflammatory properties of chitinases from Calotropis procera latex.

Authors:  Carolina Araújo Viana; Márcio V Ramos; José Delano Barreto Marinho Filho; Letícia Veras Costa Lotufo; Ingrid Samantha Tavares Figueiredo; Jefferson Soares de Oliveira; Pietro Mastroeni; José Vitor Lima-Filho; Nylane Maria Nunes Alencar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-11       Impact factor: 3.000

2.  Chitin or chitin-like glycans as targets for late-term cancer chemoprevention.

Authors:  Lee W Wattenberg; Steven Patterson; Jennifer D Antonides
Journal:  Cancer Prev Res (Phila)       Date:  2010-12

Review 3.  The mechanism of the anticancer function of M1 macrophages and their use in the clinic.

Authors:  Xing-Qing Pan
Journal:  Chin J Cancer       Date:  2012-11-13

Review 4.  Marine medicinal glycomics.

Authors:  Vitor H Pomin
Journal:  Front Cell Infect Microbiol       Date:  2014-01-29       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.